Esomeprazole (nexium).
D001682:Biological Availability; D018849:Controlled Clinical Trials as Topic; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D064098:Esomeprazole / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D004941:Esophagitis / Q000188:drug therapy; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D054328:Proton Pump Inhibitors
D003692:Delayed-Action Preparations; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064098:Esomeprazole